共 26 条
Extracorporeal life support after staged palliation of a functional single ventricle: Subsequent morbidity and survival
被引:65
作者:
Hoskote, A
Bohn, D
Gruenwald, C
Edgell, D
Cai, S
Adatia, I
Van Arsdell, G
机构:
[1] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Perfus Serv, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Cardiovasc Surg, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada
[5] Univ Toronto, Toronto, ON, Canada
关键词:
D O I:
10.1016/j.jtcvs.2005.11.035
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objective: We sought to review the outcome of infants with a functional single ventricle receiving postoperative extracorporeal life support. Methods: We reviewed all patients with a functional single ventricle receiving postoperative extracorporeal life support between January 1997 and May 2003. Results: We supported 25 infants (age range, 2-139 days; median age, 15 days; weight range, 1.9-5.9 kg; median weight, 3.4 kg) with extracorporeal life support. Operative procedures were Norwood stage 1 procedure in 18 patients, modified Blalock-Taussig shunt in 4 patients, bidirectional superior cavopulmonary shunt in 2 patients, and pulmonary vein repair in 1 patient. Indications for extracorporeal life support included cardiac arrest (14/25) and low cardiac output state (11/25). Extracorporeal membrane oxygenation was initiated in 19 patients, with conversion to a ventricular assist device in 7 patients. Ventricular assist device alone was initiated in 6 patients. Survival to decannulation was 76%, with 5 late deaths from multiorgan failure and 56% intensive care unit survival. Survival to hospital discharge was 44%. On univariate analysis, the presence of arrhythmia before extracorporeal life support (P=.005), renal failure (P=.0007), Candida species-induced sepsis (P=.026), and multiorgan failure (P=.0009) were significant risk factors in the nonsurvivors. Median hospital stay was 43.5 days (range, 6-181 days) for the whole group and 93 days (range, 36-181 days) for survivors. Eight patients completed next stage palliation. Conclusions: Twenty percent of patients were supported with a ventricular assist device alone, with 50% conversion to a ventricular assist device from extracorporeal membrane oxygenation. Survival to decannulation was encouraging. Multiorgan failure and risk of invasive infection in the post-extracorporeal membrane oxygenation period mitigate against survival to hospital discharge. Use of extracorporeal life support before cardiac arrest might reduce attrition between decannulation and hospital discharge.
引用
收藏
页码:1114 / 1121
页数:8
相关论文